Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion type Assertion NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_head.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_provenance.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion evidence source_evidence_literature NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_provenance.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion SIO_000772 22015057 NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_provenance.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion wasDerivedFrom befree-20140225 NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_provenance.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion wasGeneratedBy ECO_0000203 NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_provenance.